300158 振东制药
已收盘 07-25 15:00:00
资讯
新帖
简况
保健品概念盘中拉升，振东制药涨13.18%
市场透视 · 07-25 01:42
保健品概念盘中拉升，振东制药涨13.18%
振东制药最新公告：目前经营情况正常 不存在公司应披露而未披露的重大事项
证券之星 · 07-24 11:39
振东制药最新公告：目前经营情况正常 不存在公司应披露而未披露的重大事项
振东制药（300158）新增【驱蚊】概念
证券之星 · 07-24 08:20
振东制药（300158）新增【驱蚊】概念
山西板块盘中拉升，振东制药涨7.30%
市场透视 · 07-24 05:00
山西板块盘中拉升，振东制药涨7.30%
7月23日振东制药（300158）龙虎榜数据：游资作手新一上榜
证券之星 · 07-23
7月23日振东制药（300158）龙虎榜数据：游资作手新一上榜
异动快报：振东制药（300158）7月23日14点50分触及涨停板
证券之星 · 07-23
异动快报：振东制药（300158）7月23日14点50分触及涨停板
振东制药：中国证券登记结算有限责任公司每月于10日、20日、月末会向公司提供股东名册
证券之星 · 06-18
振东制药：中国证券登记结算有限责任公司每月于10日、20日、月末会向公司提供股东名册
医保概念盘中拉升，振东制药涨6.90%
市场透视 · 06-13
医保概念盘中拉升，振东制药涨6.90%
振东制药：公司及控股股东将持续严格遵守相关法律法规及监管要求
证券之星 · 06-09
振东制药：公司及控股股东将持续严格遵守相关法律法规及监管要求
振东制药：龙创基药业的在研产品乳杆菌二联活菌胶囊三期临床实验进展顺利
证券之星 · 05-23
振东制药：龙创基药业的在研产品乳杆菌二联活菌胶囊三期临床实验进展顺利
振东制药：公司目前无复方枣仁胶囊产品
证券之星 · 05-23
振东制药：公司目前无复方枣仁胶囊产品
振东制药：公司拥有复方苦参注射液、达霏欣牌米诺地尔搽剂等多个独家或领先产品
证券之星 · 05-23
振东制药：公司拥有复方苦参注射液、达霏欣牌米诺地尔搽剂等多个独家或领先产品
振东制药上涨9.57%，报4.35元/股
金融界 · 05-20
振东制药上涨9.57%，报4.35元/股
振东制药获得发明专利授权：“一种可掩盖苦味的女金丸制备方法”
证券之星 · 04-29
振东制药获得发明专利授权：“一种可掩盖苦味的女金丸制备方法”
振东制药：复方胰酶散为公司子公司产品
证券之星 · 04-25
振东制药：复方胰酶散为公司子公司产品
振东制药董事长李昆：中医药企业国际化首先要做好质量和科研
第一财经 · 04-25
振东制药董事长李昆：中医药企业国际化首先要做好质量和科研
振东制药：公司创新药研究围绕抗肿瘤、皮科、泌尿等管线开展
证券之星 · 04-24
振东制药：公司创新药研究围绕抗肿瘤、皮科、泌尿等管线开展
振东制药：公司营销网络已实现规模化布局
证券之星 · 04-24
振东制药：公司营销网络已实现规模化布局
振东制药：公司暂未开展中药减肥产品方面的研究
证券之星 · 04-24
振东制药：公司暂未开展中药减肥产品方面的研究
振东制药(300158.SZ)发布2024年度业绩，归母净亏损13.29亿元
智通财经网 · 04-20
振东制药(300158.SZ)发布2024年度业绩，归母净亏损13.29亿元
加载更多
公司概况
公司名称：
山西振东制药股份有限公司
所属行业：
医药制造业
上市日期：
2011-01-07
主营业务：
山西振东制药股份有限公司的主营业务是肿瘤、皮科、消化、泌尿、心脑等仿制药、创新药的研发、生产、销售，以及种子种苗抚育、种植、加工、仓储、饮片于一体的中药材全产业链。公司的主要产品是复方苦参注射液、米诺地尔搽剂、生白颗粒、舒血宁注射液、西黄丸、独一味颗粒、复方胰酶散、大山楂丸。
发行价格：
38.80
{"stockData":{"symbol":"300158","market":"SZ","secType":"STK","nameCN":"振东制药","latestPrice":7.03,"timestamp":1753427025000,"preClose":6.45,"halted":0,"volume":243966008,"delay":0,"changeRate":0.0899,"floatShares":1002999999,"shares":1005000000,"eps":-1.3434,"marketStatus":"已收盘","change":0.58,"latestTime":"07-25 15:00:00","open":6.45,"high":7.6,"low":6.45,"amount":1741000000,"amplitude":0.1783,"askPrice":7.04,"askSize":2156,"bidPrice":7.03,"bidSize":4495,"shortable":0,"etf":0,"ttmEps":-1.3434,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753666200000},"marketStatusCode":5,"adr":0,"adjPreClose":6.45,"symbolType":"stock","openAndCloseTimeList":[[1753407000000,1753414200000],[1753419600000,1753426800000]],"highLimit":7.1,"lowLimit":5.81,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1005319756,"isCdr":false,"pbRate":1.77,"roa":"--","roe":"0.03%","epsLYR":-1.2977,"committee":0.578416,"marketValue":7067000000,"turnoverRate":0.2433,"status":0,"floatMarketCap":7048000000},"requestUrl":"/m/hq/s/300158","defaultTab":"news","newsList":[{"id":"2554732915","title":"保健品概念盘中拉升，振东制药涨13.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554732915","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554732915?lang=zh_cn&edition=full","pubTime":"2025-07-25 09:42","pubTimestamp":1753407759,"startTime":"0","endTime":"0","summary":"07月25日，保健品概念盘中拉升，截至09点42分，保健品概念整体指数上涨0.50%，报1316.340点。从个股上来看，该概念的成分股中，振东制药涨13.18%，交大昂立、百合股份、百龙创园涨幅居前。从资金上来看，截止发稿，保健品概念概念主力净流入为4894.75万，其中振东制药受到资金热捧，主力净流入7712.89万；拉长时间线来看，该板块近20日主力资金净流入-33.44亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072509423994b96bfa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072509423994b96bfa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0226","BK0060","300158","600530","BK0114","BK0122","603102","605016","BK0239","BK0186"],"gpt_icon":0},{"id":"2553820745","title":"振东制药最新公告：目前经营情况正常 不存在公司应披露而未披露的重大事项","url":"https://stock-news.laohu8.com/highlight/detail?id=2553820745","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553820745?lang=zh_cn&edition=full","pubTime":"2025-07-24 19:39","pubTimestamp":1753357174,"startTime":"0","endTime":"0","summary":"振东制药公告称，公司股票交易价格连续两个交易日内收盘价涨幅偏离值累计超过30％，属于股票交易异常波动情况。经核查，公司、控股股东和实际控制人不存在关于公司的应披露而未披露的重大事项，也不存在处于筹划阶段的重大事项。公司不存在违反信息公平披露的情形。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072400032787.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0060","300158","BK0186"],"gpt_icon":0},{"id":"2553766277","title":"振东制药（300158）新增【驱蚊】概念","url":"https://stock-news.laohu8.com/highlight/detail?id=2553766277","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553766277?lang=zh_cn&edition=full","pubTime":"2025-07-24 16:20","pubTimestamp":1753345212,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，7月24日振东制药新增概念。振东制药主营业务：肿瘤、毛发、消化、泌尿、心脑等仿制药、创新药的研发、生产、销售,以及种子种苗抚育、种植、加工、仓储、饮片于一体的中药材全产业链。振东制药2025年一季报显示，公司主营收入7.55亿元，同比下降3.53%；归母净利润115.72万元，同比下降94.99%；扣非净利润28.96万元，同比上升103.37%；负债率21.81%，投资收益341.62万元，财务费用31.15万元，毛利率49.09%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072400024773.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0186","BK0060","BK0239","300158"],"gpt_icon":0},{"id":"2553275966","title":"山西板块盘中拉升，振东制药涨7.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553275966","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553275966?lang=zh_cn&edition=full","pubTime":"2025-07-24 13:00","pubTimestamp":1753333250,"startTime":"0","endTime":"0","summary":"07月24日，山西板块盘中拉升，截至13点00分，山西板块整体指数上涨1.03%，报3156.750点。从个股上来看，该板块的成分股中，振东制药涨7.30%，永泰能源、潞安环能2只股涨幅超过5%。从资金上来看，截止发稿，山西板块主力净流入为1.76亿，其中永泰能源受到资金热捧，主力净流入2.45亿；拉长时间线来看，该板块近20日主力资金净流入-19.79亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072413005094b783e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072413005094b783e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["601699","BK0060","300158","BK0186","BK0028","BK0239","BK0188","BK0266","BK0164","BK0185","BK0183"],"gpt_icon":0},{"id":"2553215902","title":"7月23日振东制药（300158）龙虎榜数据：游资作手新一上榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2553215902","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553215902?lang=zh_cn&edition=full","pubTime":"2025-07-23 17:20","pubTimestamp":1753262457,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2025年7月23日公布的交易公开信息显示，振东制药因日涨幅达到15%的前5只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2025年7月23日收盘，振东制药报收于5.89元，上涨19.96%，涨停，换手率16.68%，成交量167.19万手，成交额9.11亿元。从龙虎榜公布的当日买卖数据来看，北向资金合计净卖出3344.36万元。作手新一等知名游资榜上有名。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072300029121.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0186","BK0060","300158"],"gpt_icon":0},{"id":"2553294599","title":"异动快报：振东制药（300158）7月23日14点50分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2553294599","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553294599?lang=zh_cn&edition=full","pubTime":"2025-07-23 14:55","pubTimestamp":1753253722,"startTime":"0","endTime":"0","summary":"证券之星7月23日盘中消息，14点50分振东制药触及涨停板。目前价格5.89，上涨19.96%。其所属行业中药目前下跌。该股为肝炎概念，幽门螺杆菌概念，土地流转概念热股，当日肝炎概念概念上涨0.77%，幽门螺杆菌概念概念上涨0.37%。7月23日的资金流向数据方面，主力资金净流入2039.44万元，占总成交额13.02%，游资资金净流出1078.15万元，占总成交额6.88%，散户资金净流出961.29万元，占总成交额6.14%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072300019922.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0060","BK0186","BK0239","300158"],"gpt_icon":0},{"id":"2544697746","title":"振东制药：中国证券登记结算有限责任公司每月于10日、20日、月末会向公司提供股东名册","url":"https://stock-news.laohu8.com/highlight/detail?id=2544697746","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544697746?lang=zh_cn&edition=full","pubTime":"2025-06-18 20:51","pubTimestamp":1750251069,"startTime":"0","endTime":"0","summary":"证券之星消息，振东制药06月17日在投资者关系平台上答复投资者关心的问题。盼你们具体，明确答复。顺祝健康，快乐 【比如截至到2025年6月10日贵公司的股东人数是多少？...振东制药回复：尊敬的投资者您好！中国证券登记结算有限责任公司每月于10日、20日、月末会向公司提供股东名册。请将您的股东证明文件发送至公司邮箱，公司核实您的股东身份后，将在3个工作日内通过邮件或电话的方式回复您最新的股东人数。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061800035324.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300158","BK0239","BK0186","BK0060","161027"],"gpt_icon":0},{"id":"2543524743","title":"医保概念盘中拉升，振东制药涨6.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2543524743","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543524743?lang=zh_cn&edition=full","pubTime":"2025-06-13 09:37","pubTimestamp":1749778631,"startTime":"0","endTime":"0","summary":"06月13日，医保概念盘中拉升，截至09点37分，医保概念整体指数上涨0.53%，报1326.280点。从个股上来看，该概念的成分股中，振东制药涨6.90%，奥赛康涨幅超过5%。从资金上来看，截止发稿，医保概念主力净流入为-1.21亿，其中恒瑞医药受到资金热捧，主力净流入1526.81万；拉长时间线来看，该板块近20日主力资金净流入-68.94亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613093711a4a6428b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613093711a4a6428b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["300158","BK0060","LU2328871848.SGD","LU1969619763.USD","BK0239","BK0188","LU0405327148.USD","LU0405327494.USD","BK0186","600276","LU1064131003.USD","LU2148510915.USD","BK0012","LU2488822045.USD","BK0196","BK0183","BK0028","LU1328615791.USD","LU1064130708.USD"],"gpt_icon":0},{"id":"2542382478","title":"振东制药：公司及控股股东将持续严格遵守相关法律法规及监管要求","url":"https://stock-news.laohu8.com/highlight/detail?id=2542382478","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542382478?lang=zh_cn&edition=full","pubTime":"2025-06-09 20:51","pubTimestamp":1749473484,"startTime":"0","endTime":"0","summary":"证券之星消息，振东制药06月09日在投资者关系平台上答复投资者关心的问题。综上，经审慎判断，控股股东振东集团除本公司外的其他产业，与公司当前的主营业务不存在实质性同业竞争关系。公司及控股股东将持续严格遵守相关法律法规及监管要求，切实维护上市公司及全体股东的合法权益。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060900031060.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0060","300158","BK0186"],"gpt_icon":0},{"id":"2537153131","title":"振东制药：龙创基药业的在研产品乳杆菌二联活菌胶囊三期临床实验进展顺利","url":"https://stock-news.laohu8.com/highlight/detail?id=2537153131","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537153131?lang=zh_cn&edition=full","pubTime":"2025-05-23 20:56","pubTimestamp":1748005017,"startTime":"0","endTime":"0","summary":"证券之星消息，振东制药(300158)05月23日在投资者关系平台上答复投资者关心的问题。投资者提问：公司拟最高4.62亿元收购创新药在研企业龙创基药业部分股权进展如何？请介绍，谢谢。振东制药回复：尊敬的投资者您好！龙创基药业的在研产品乳杆菌二联活菌胶囊三期临床实验进展顺利，已完成入组。如有涉及披露事项公司会及时公告。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052300039220.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300158","BK0239","BK0060","BK0186"],"gpt_icon":0},{"id":"2537131174","title":"振东制药：公司目前无复方枣仁胶囊产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2537131174","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537131174?lang=zh_cn&edition=full","pubTime":"2025-05-23 20:56","pubTimestamp":1748005012,"startTime":"0","endTime":"0","summary":"证券之星消息，振东制药(300158)05月23日在投资者关系平台上答复投资者关心的问题。投资者提问：请问，公司有复方枣仁胶囊产品吗？市场销售情况如何。振东制药回复：尊敬的投资者您好！公司目前无该产品。公司治疗失眠类产品酸枣仁合剂，适应症涵盖失眠多梦、心悸烦躁等，与复方枣仁胶囊具有相似临床功效。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052300039214.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300158","BK0186","BK0060","BK0239"],"gpt_icon":0},{"id":"2537131129","title":"振东制药：公司拥有复方苦参注射液、达霏欣牌米诺地尔搽剂等多个独家或领先产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2537131129","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537131129?lang=zh_cn&edition=full","pubTime":"2025-05-23 20:54","pubTimestamp":1748004892,"startTime":"0","endTime":"0","summary":"证券之星消息，振东制药(300158)05月22日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司在市场上最具竞争力和知名度的产品是什么？振东制药回复：尊敬的投资者您好！公司拥有复方苦参注射液、达霏欣牌米诺地尔搽剂、岩列舒牌比卡鲁胺胶囊等多个独家或领先产品，覆盖抗肿瘤、皮科、泌尿等重点领域。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052300039081.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300158","BK0186","BK0060","BK0239"],"gpt_icon":0},{"id":"2536256663","title":"振东制药上涨9.57%，报4.35元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2536256663","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536256663?lang=zh_cn&edition=full","pubTime":"2025-05-20 11:06","pubTimestamp":1747710399,"startTime":"0","endTime":"0","summary":"5月20日，振东制药盘中上涨9.57%，截至11:06，报4.35元/股，成交1.4亿元，换手率3.42%，总市值43.73亿元。截至9月30日，振东制药股东户数5.33万，人均流通股1.88万股。2024年1月-9月，振东制药实现营业收入22.69亿元，同比减少18.48%；归属净利润4012.33万元，同比增长4689.69%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/05/20110650524192.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0186","BK0060","BK0239","300158"],"gpt_icon":0},{"id":"2531791657","title":"振东制药获得发明专利授权：“一种可掩盖苦味的女金丸制备方法”","url":"https://stock-news.laohu8.com/highlight/detail?id=2531791657","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531791657?lang=zh_cn&edition=full","pubTime":"2025-04-30 04:04","pubTimestamp":1745957098,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示振东制药新获得一项发明专利授权，专利名为“一种可掩盖苦味的女金丸制备方法”，专利申请号为CN202311479659.5，授权日为2025年4月29日。本发明通过超微粉碎及干法压片对苦味药材进行有效掩盖，明显减轻了女金丸成药的苦味，改善了产品的口感。今年以来振东制药新获得专利授权3个，较去年同期增加了200%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025043000003537.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300158","BK0239","BK0060","BK0186"],"gpt_icon":0},{"id":"2530813383","title":"振东制药：复方胰酶散为公司子公司产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2530813383","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530813383?lang=zh_cn&edition=full","pubTime":"2025-04-25 20:52","pubTimestamp":1745585536,"startTime":"0","endTime":"0","summary":"证券之星消息，振东制药04月24日在投资者关系平台上答复投资者关心的问题。投资者提问：你好董秘：从公司2025年季报披露公司新增了一家：山西远景康业制药公司100%控股！复方姨酶散就是这家公司的准字药品吗？谢谢振东制药回复：尊敬的投资者您好！复方胰酶散为公司子公司山西振东安欣生物制药有限公司的产品，是公司结合批文资源与营销管线布局而“老品激活”的品种；山西远景康业制药公司为山西振东安欣生物制药有限公司的子公司。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042500034553.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300158","BK0060","BK0239","BK0186"],"gpt_icon":0},{"id":"2530590001","title":"振东制药董事长李昆：中医药企业国际化首先要做好质量和科研","url":"https://stock-news.laohu8.com/highlight/detail?id=2530590001","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530590001?lang=zh_cn&edition=full","pubTime":"2025-04-25 18:32","pubTimestamp":1745577141,"startTime":"0","endTime":"0","summary":"4月25日，在2025企业可持续发展大会“可持续出海重塑全球商业与健康格局”分论坛上，振东制药董事长李昆发表了主题演讲《构建中药“新丝路”，从田间管理到走向国际的标准化模式》，讲述了其所在企业探索国际化发展的一些思路。李昆表示，他们做国际化的思路主要有两个，一个是质量，一个是科研，最后才考虑市场。为了保证中药产品质量，多年来，振东制药已在探索中药材如何进行追溯。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425183306a466ae0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425183306a466ae0d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["561510","BK0186","562390","BK0239","BK0060","300158"],"gpt_icon":0},{"id":"2529379987","title":"振东制药：公司创新药研究围绕抗肿瘤、皮科、泌尿等管线开展","url":"https://stock-news.laohu8.com/highlight/detail?id=2529379987","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529379987?lang=zh_cn&edition=full","pubTime":"2025-04-24 20:51","pubTimestamp":1745499080,"startTime":"0","endTime":"0","summary":"证券之星消息，振东制药04月23日在投资者关系平台上答复投资者关心的问题。投资者提问：你好董秘：2024年年报说明公司接下来要转型创新药为主攻方向，请问还是在皮科与肿瘤方向吗？公司创新药研究围绕抗肿瘤、皮科、泌尿等管线开展；公司产品生发片在京东和阿里平台上均已挂网销售，您可在相关平台上搜“达霏欣生发片”购买。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042400038154.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300158","BK1574","BK0186","BK0239","159992","06978","BK0060","BK1161"],"gpt_icon":0},{"id":"2529987895","title":"振东制药：公司营销网络已实现规模化布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2529987895","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529987895?lang=zh_cn&edition=full","pubTime":"2025-04-24 20:51","pubTimestamp":1745499078,"startTime":"0","endTime":"0","summary":"证券之星消息，振东制药04月23日在投资者关系平台上答复投资者关心的问题。投资者提问：你好董秘：2024年报披露，公司营收29亿，集团营收60亿，集团业务除上市公司外已经首次超过！公司以脾肾两助丸为抓手，以中药类产品集群为增长引擎，通过品牌驱动实现“群品进终端”。目前公司营销网络已实现规模化布局，已覆盖经销商626家，代理商287个，诊所、民营医院5,000家，单体药店3,000家。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042400038151.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0186","BK0060","BK0239","300158"],"gpt_icon":0},{"id":"2529873499","title":"振东制药：公司暂未开展中药减肥产品方面的研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2529873499","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529873499?lang=zh_cn&edition=full","pubTime":"2025-04-24 20:51","pubTimestamp":1745499075,"startTime":"0","endTime":"0","summary":"证券之星消息，振东制药04月23日在投资者关系平台上答复投资者关心的问题。看年报公司开启2025“破局年”！公司暂未开展中药减肥产品方面的研究；公司战略并购情况请您参阅公司《2024年年度报告》第三节“管理层讨论与分析”相关内容。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042400038147.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300158","BK0186","BK0060"],"gpt_icon":0},{"id":"2528854489","title":"振东制药(300158.SZ)发布2024年度业绩，归母净亏损13.29亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528854489","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528854489?lang=zh_cn&edition=full","pubTime":"2025-04-20 17:11","pubTimestamp":1745140309,"startTime":"0","endTime":"0","summary":"振东制药(300158.SZ)发布2024年年度报告，报告期内，公司实现营业收入2...","market":"hk","thumbnail":"https://img.zhitongcaijing.com/astock/13.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/13.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1281238.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["300158","BK0060","BK0239","BK0186"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1753544038961,"stockEarnings":[{"period":"1week","weight":0.4289},{"period":"1month","weight":0.5727},{"period":"3month","weight":0.7708},{"period":"6month","weight":0.85},{"period":"1year","weight":0.8549},{"period":"ytd","weight":0.6273}],"compareEarnings":[{"period":"1week","weight":0.0167},{"period":"1month","weight":0.0398},{"period":"3month","weight":0.0906},{"period":"6month","weight":0.1048},{"period":"1year","weight":0.2449},{"period":"ytd","weight":0.0722}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"山西振东制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"48584人(较上一季度减少3.92%)","perCapita":"20635股","listingDate":"2011-01-07","address":"山西省长治市上党区光明南路振东科技园","registeredCapital":"100531万元","survey":" 山西振东制药股份有限公司的主营业务是肿瘤、皮科、消化、泌尿、心脑等仿制药、创新药的研发、生产、销售，以及种子种苗抚育、种植、加工、仓储、饮片于一体的中药材全产业链。公司的主要产品是复方苦参注射液、米诺地尔搽剂、生白颗粒、舒血宁注射液、西黄丸、独一味颗粒、复方胰酶散、大山楂丸。","listedPrice":38.8},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"振东制药(300158)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供振东制药(300158)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"振东制药,300158,振东制药股票,振东制药股票老虎,振东制药股票老虎国际,振东制药行情,振东制药股票行情,振东制药股价,振东制药股市,振东制药股票价格,振东制药股票交易,振东制药股票购买,振东制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"振东制药(300158)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供振东制药(300158)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}